Recent report on indoles as a privileged anti-viral scaffold in drug discovery.

Publication date: Jan 05, 2025

In recent years, viral infections such as COVID-19, Zika virus, Nipah virus, Ebola, Influenza, Monkeypox, and Dengue have substantially impacted global health. These outbreaks have led to heightened global health initiatives and collaborative efforts to address and mitigate these significant threats effectively. Thus, developing antiviral treatments and research in this field has become highly important. Heterocycles, particularly indole motifs, have been a valuable resource in drug discovery, as they can be used as treatments or inspire the synthesis of new potent candidates. Indole-containing drugs, such as enfuvirtide (T-20), arbidol, and delavirdine, have demonstrated significant efficacy in treating viral diseases. This review aims to comprehensively assess the latest research and developments in novel indoles as potential scaffolds for antiviral activity. We have compiled detailed information about indoles as potential antivirals by conducting a thorough literature survey from the past ten years. The review includes discussions on synthetic protocols, inhibitory concentrations, SAR study, and computational study. This review shall identify new antiviral indoles that may help to combat new viral threats in the future.

Concepts Keywords
Antiviral Animals
Conducting Antiviral
Future Antiviral Agents
Monkeypox Antiviral Agents
Viral DENV
Drug Discovery
Hepatitis
HIV
Humans
Indole
Indoles
Indoles
Influenza
Molecular Structure
SAR
SARS-CoV-2
SARS-CoV-2
Structure-Activity Relationship
Virus Diseases
Zika virus

Semantics

Type Source Name
disease MESH viral infections
disease MESH COVID-19
disease MESH Influenza
disease MESH Monkeypox
disease MESH Dengue
drug DRUGBANK Indole
drug DRUGBANK Enfuvirtide
drug DRUGBANK Delavirdine
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH Hepatitis

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *